
At Andrew Potocki’s follow-up appointment 15 days after his surgery for an ameloblastoma in his jaw, Dr. Matthew Spector, MD, FACS, Division Chief, Head and Neck Surgical Oncology & Microvascular […]
At Andrew Potocki’s follow-up appointment 15 days after his surgery for an ameloblastoma in his jaw, Dr. Matthew Spector, MD, FACS, Division Chief, Head and Neck Surgical Oncology & Microvascular […]
CD8+ tumor-infiltrating lymphocytes (TILs) are immune cells that play a key role in the body’s response to cancer. As a result, they have been used across oncology to help assess […]
Read More… from Promising Biomarker for Personalizing HNC Care
The December 2024 issue of Oral Oncology has an article co-authored by three members of the Department of Otolaryngology-Head & Neck Surgery at the University of Pittsburgh, along with colleagues […]
Read More… from Measuring Functional Outcomes in Tongue Surgery
There are two main parts to Matthew Spector’s research. The Division Chief of Head and Neck Surgical Oncology & Microvascular Reconstruction, who has a MD and FACS, said in the […]
Read More… from The Rehabilitation of Head and Neck Cancer Patients
Hot off the press is an article written by three members of the Department of Otolaryngology-Head & Neck Surgery at the University of Pittsburgh, along with authors from the Department […]
Read More… from Paper on Novel Technique for PPS Tumor Removal